Overview
Diverticulitis of the descending colon represents an inflammatory condition affecting the diverticula, which are sac-like protrusions in the colonic wall. This condition is a severe manifestation of diverticular disease (DD), often leading to significant morbidity and occasionally mortality. It predominantly affects older adults, with incidence increasing with age, particularly in those over 60 years. The descending colon is one of several segments where diverticula can form, but involvement here can present unique challenges due to anatomical considerations. Understanding and managing diverticulitis effectively is crucial in day-to-day practice to prevent complications such as abscess formation, perforation, and sepsis, thereby improving patient outcomes and reducing healthcare burden 13.Pathophysiology
The pathophysiology of diverticulitis involves the progressive weakening of the colonic wall, often due to factors like chronic low-fiber diet, increased intraluminal pressure, and genetic predisposition. Once diverticula form, they can become inflamed when fecal matter or other irritants obstruct the narrow neck of these sacs, leading to localized ischemia and subsequent inflammation. This inflammatory cascade triggers an immune response, characterized by neutrophil infiltration and the release of pro-inflammatory cytokines, which can exacerbate tissue damage and potentially lead to complications such as abscess formation or perforation. The descending colon, due to its specific anatomical position and blood supply, may experience unique hemodynamic stresses that influence the severity and progression of inflammation 12.Epidemiology
Diverticulitis, including involvement of the descending colon, predominantly affects individuals over 50 years of age, with incidence rates rising sharply after 60. The prevalence is higher in Western populations compared to others, likely due to dietary habits, with low fiber intake being a significant risk factor. Gender distribution shows a slight male predominance, though this can vary. Geographic trends indicate higher incidences in industrialized countries where Western diets are prevalent. Over time, the incidence of diverticulitis has increased, paralleling lifestyle changes and aging populations. Risk factors include obesity, smoking, sedentary lifestyle, and the use of nonsteroidal anti-inflammatory drugs (NSAIDs). These factors collectively contribute to the growing burden of diverticulitis in healthcare systems 12.Clinical Presentation
Patients with diverticulitis of the descending colon typically present with nonspecific symptoms such as abdominal pain, often localized to the left lower quadrant, which can radiate to the back. Pain is usually constant and severe, exacerbated by movement. Other common symptoms include nausea, vomiting, anorexia, and fever, especially in cases of complicated diverticulitis. Atypical presentations might include vague abdominal discomfort or symptoms mimicking irritable bowel syndrome. Red-flag features that necessitate urgent evaluation include significant abdominal tenderness, guarding, rebound tenderness, and signs of peritonitis, such as rigidity and pain on palpation. These clinical features guide the need for prompt diagnostic evaluation to differentiate diverticulitis from other acute abdominal conditions 3.Diagnosis
The diagnosis of diverticulitis, particularly involving the descending colon, relies on a combination of clinical assessment and imaging. Initial evaluation includes a thorough history and physical examination to identify signs of peritoneal irritation or systemic inflammatory response. Key diagnostic criteria and tests include:Clinical Criteria:
- Persistent left lower quadrant pain
- Fever (typically >38°C)
- Nausea and vomiting
- Leukocytosis (white blood cell count >10,000/μL)Imaging:
- CT Abdomen: The gold standard, showing characteristic findings such as colonic wall thickening, pericolic fat stranding, and sometimes an abscess or phlegmon.
- Ultrasound: Useful in specific scenarios, particularly in pregnant patients, but less sensitive compared to CT.Differential Diagnosis:
- Acute Appendicitis: Typically presents with right lower quadrant pain, localized rebound tenderness.
- Ovarian Cyst Rupture/Torsion: More common in premenopausal women, with pelvic tenderness and adnexal masses on ultrasound.
- Colorectal Cancer: Persistent changes in bowel habits, weight loss, and mass on examination; imaging shows a mass rather than inflammatory changes.(Evidence: Moderate) 23
Management
Initial Management
Supportive Care:
- Fluid Resuscitation: Intravenous fluids to maintain hydration and hemodynamic stability.
- Nutritional Support: Initially nil per os (NPO), progressing to clear liquids, then advancing as tolerated.
- Pain Management: Analgesics such as opioids for severe pain, with careful monitoring for respiratory depression.Antibiotics:
- First-Line: Ciprofloxacin 400 mg IV every 12 hours plus metronidazole 500 mg IV every 8 hours.
- Alternative: Amoxicillin-clavulanate 1.2 g IV every 8 hours if ciprofloxacin contraindicated.
- Duration: Typically 7-10 days, adjusted based on clinical response and imaging findings.Complicated Diverticulitis
Abscess Drainage: Percutaneous drainage under CT guidance if abscess is present.
Surgical Intervention: Considered for complications such as perforation, obstruction, or persistent sepsis unresponsive to medical management. Options include:
- Resection: Hartmann’s procedure (resection with end colostomy) or primary anastomosis, depending on the extent of disease and patient condition.
- Monitoring: Close observation in high-risk patients with multidisciplinary team involvement.Prevention and Secondary Prevention
Mesalazine (5-ASA):
- Primary Prevention: Evidence is mixed; some studies suggest potential benefit in preventing first episodes in patients with symptomatic uncomplicated diverticular disease (SUDD).
- Secondary Prevention: Limited evidence supports its role in preventing recurrence, though it remains an area of ongoing research.
- Dose: Typically 2.4-3 grams daily, divided into smaller doses.
- Duration: Long-term use may be considered based on individual risk factors.Lifestyle Modifications:
- Dietary Fiber: Increased intake to soften stool and reduce intraluminal pressure.
- Weight Management: Weight loss in obese patients.
- Smoking Cessation: Quitting smoking to reduce risk factors.(Evidence: Moderate to Weak) 13
Complications
Acute Complications:
- Abscess Formation: Requires percutaneous drainage or surgical intervention.
- Perforation: Leads to peritonitis, necessitating urgent surgical repair.
- Fistula Formation: Often requires surgical management, especially if involving adjacent organs.
- Stricture Formation: May require endoscopic dilation or surgical correction.Long-Term Complications:
- Chronic Inflammation: Potential for recurrent episodes and increased risk of colorectal cancer.
- Bowel Obstruction: Secondary to scarring or stricture formation.Referral Triggers:
Persistent symptoms despite medical management.
Signs of peritonitis or systemic sepsis.
Complicated presentations requiring surgical intervention.(Evidence: Moderate) 2
Prognosis & Follow-up
The prognosis for diverticulitis varies based on the severity and presence of complications. Patients with uncomplicated diverticulitis generally have a good prognosis with appropriate medical management, often resolving within 2-4 weeks. Prognostic indicators include the absence of complications, prompt response to antibiotics, and resolution of inflammatory markers. Follow-up typically involves:Initial Follow-Up: Within 2-4 weeks post-resolution to ensure no recurrence and assess for complications.
Long-Term Monitoring: Regular physical exams and possibly periodic imaging if there is a history of recurrent episodes or complications.
Dietary Counseling: Ongoing support to maintain a high-fiber diet and lifestyle modifications.(Evidence: Moderate) 13
Special Populations
Elderly Patients: Higher risk of complications; close monitoring and conservative management favored initially.
Pregnancy: Ultrasound preferred over CT; management focuses on conservative care with close obstetric surveillance.
Comorbidities: Patients with comorbidities like cardiovascular disease or renal impairment require tailored antibiotic choices and close monitoring of organ function.(Evidence: Moderate) 3
Key Recommendations
Initial Management with Supportive Care and Antibiotics: Initiate intravenous fluids, nil per os, and broad-spectrum antibiotics (e.g., ciprofloxacin and metronidazole) for 7-10 days in uncomplicated diverticulitis. (Evidence: Strong) 3
Consider CT Abdomen for Diagnosis: Use CT imaging to confirm diagnosis and assess for complications such as abscess or perforation. (Evidence: Strong) 2
Mesalazine for Secondary Prevention: Consider long-term mesalazine use in patients with recurrent diverticulitis, though evidence is mixed. (Evidence: Moderate) 1
Lifestyle Modifications Essential: Encourage high-fiber diet, weight management, and smoking cessation to reduce recurrence risk. (Evidence: Moderate) 3
Surgical Intervention for Complicated Cases: Proceed with surgical options like Hartmann’s procedure or primary anastomosis for complications such as perforation or persistent sepsis. (Evidence: Moderate) 2
Close Monitoring for Recurrence: Schedule follow-up visits within 2-4 weeks post-resolution to monitor for recurrence and manage complications effectively. (Evidence: Moderate) 1
Tailored Management in Special Populations: Adjust treatment strategies for elderly patients, pregnant women, and those with significant comorbidities. (Evidence: Moderate) 3
Avoid Unnecessary Antibiotic Use: Limit antibiotic therapy to cases where clinical suspicion of diverticulitis is high, avoiding overuse in low-risk scenarios. (Evidence: Moderate) 3
Refer for Complex Cases: Escalate care to surgical consultation for patients with signs of peritonitis, persistent fever, or other severe complications. (Evidence: Moderate) 2
Educate on Dietary Fiber Intake: Emphasize the importance of dietary fiber to soften stools and reduce intraluminal pressure, thereby lowering the risk of recurrence. (Evidence: Moderate) 1(Evidence: Strong, Moderate, Weak, Expert opinion) 123
References
1 Stefanelli G, Viscido A, Valvano M, Vernia F, Frieri G, Ashktorab H et al.. Is mesalazine treatment effective in the prevention of diverticulitis? A review. European review for medical and pharmacological sciences 2020. link
2 Tan JP, Barazanchi AW, Singh PP, Hill AG, Maccormick AD. Predictors of acute diverticulitis severity: A systematic review. International journal of surgery (London, England) 2016. link
3 Tursi A. New medical strategies for the management of acute diverticulitis. Expert review of gastroenterology & hepatology 2015. link